Skip to content
Home/Companies/Biotech/Aros Applied Biotechnology

Aros Applied Biotechnology

Biotech·Denmark·Exited 2013·Held 13yr
Entry
2000
Hold
13yr
Exit
2013

Who owns Aros Applied Biotechnology?

Aros Applied Biotechnology is a Danish Biotech company, now owned by Eurofins, which acquired it in 2013 from Capnova.

Hand-verified · updated 2026-08-19

Open JSON · CC-BY
Capnova
Investor
Capnova
CAPNOVA · 1998 · VC

Key facts

HQDenmark
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
Eurofins
Exit Year
2013

More from CAPNOVA

Other portfolio companies in the same fund.

Triband
Exited 2020
GamingDenmark· 2016
to Triband ApS
SynAct Pharma
Exited 2016
BiotechDenmark· 2012
SYBO Games
Exited 2012
GamingDenmark· 2011
Action Pharma
Exited 2012
BiotechDenmark· 2002
to Abbott
MediConnect
Exited 2005
HealthTechDenmark· 2001
to Kommuneinformation A/S (now part of EG)

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Aros Applied Biotechnology?

Aros Applied Biotechnology is now owned by Eurofins, which acquired it in 2013 from Capnova.

When did Eurofins acquire Aros Applied Biotechnology?

Eurofins acquired Aros Applied Biotechnology in 2013, buying from Capnova.

Who did Aros Applied Biotechnology sell to?

Capnova sold Aros Applied Biotechnology to Eurofins in 2013 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue